108 results
Page 4 of 6
424B3
EX-10.1
5rujqt8ibmjy3k z922i
12 Nov 21
Prospectus supplement
8:41am
424B3
3v9r44iwcc5iffs7337m
28 Sep 21
Prospectus supplement
9:07am
8-K
EX-99.1
o84fmvp
28 Sep 21
Entry into a Material Definitive Agreement
8:53am
8-K
EX-99.1
7uyr3gx
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
8wkj7p9ib9l
5 Aug 21
Prospectus supplement
4:26pm
8-K
EX-10.5
x22mufrl3
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.6
01y1yx5m 200
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.4
hpklbexcrh 1a7x28
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.7
ov1g1 qkgwb2ja2my
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.2
9xtlzus8qv17d2fre
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.8
apsf4m8wb6ctg4uq3 d3
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
424B3
xffov
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.16
fm7qdinmfsoo537py yi
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.13
arsognfdgra974x9a
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
ur02gys9
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.19
kwkthsz
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm